4YDF
Crystal structure of compound 9 in complex with HTLV-1 Protease
4YDF の概要
| エントリーDOI | 10.2210/pdb4ydf/pdb |
| 関連するPDBエントリー | 3LIX 3WSJ |
| 分子名称 | HTLV-1 Protease, N-benzyl-N-[(3S,4S)-4-{benzyl[(4-nitrophenyl)sulfonyl]amino}pyrrolidin-3-yl]-3-nitrobenzenesulfonamide, SULFATE ION, ... (4 entities in total) |
| 機能のキーワード | htlv-1 protease, hydrolase |
| 由来する生物種 | Human T-lymphotropic virus 1 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 25880.93 |
| 構造登録者 | Kuhnert, M.,Blum, A.,Steuber, H.,Diederich, W.E. (登録日: 2015-02-22, 公開日: 2016-02-03, 最終更新日: 2024-01-10) |
| 主引用文献 | Kuhnert, M.,Blum, A.,Steuber, H.,Diederich, W.E. Privileged Structures Meet Human T-Cell Leukemia Virus-1 (HTLV-1): C2-Symmetric 3,4-Disubstituted Pyrrolidines as Nonpeptidic HTLV-1 Protease Inhibitors. J.Med.Chem., 58:4845-4850, 2015 Cited by PubMed Abstract: 3,4-disubstituted pyrrolidines originally designed to inhibit the closely related HIV-1 protease were evaluated as privileged structures against HTLV-1 protease (HTLV-1 PR). The most potent inhibitor of this series exhibits two-digit nanomolar affinity and represents, to the best of our knowledge, the most potent nonpeptidic inhibitor of HTLV-1 PR described so far. The X-ray structures of two representatives bound to HTLV-1 PR were determined, and the structural basis of their affinity is discussed. PubMed: 26000468DOI: 10.1021/acs.jmedchem.5b00346 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.804 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






